G Ignatyev

Summary

Affiliation: State Research Center of Virology and Biotechnology Vector
Country: Russia

Publications

  1. ncbi Changes in immunoreactivity of orexin-A-positive neurons after intravenous lipopolysaccharide injection
    Sofia V Perekrest
    Department of General Pathology and Pathophysiology, State Research Institute of Experimental Medicine RAMS, Saint Petersburg, Russia
    Med Sci Monit 14:BR127-33. 2008
  2. ncbi Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection
    Alena Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, Russia
    FEMS Immunol Med Microbiol 35:33-42. 2003
  3. ncbi Experimental study on the possibility of treatment of some hemorrhagic fevers
    G Ignatyev
    State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, 633159, Koltsovo, Russia
    J Biotechnol 83:67-76. 2000
  4. ncbi Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003
    Alena V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region, Russia
    Vaccine 25:4651-8. 2007
  5. ncbi Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus
    A V Atrasheuskaya
    Laboratory of Immunology Safety, Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
    Vaccine 24:1530-6. 2006
  6. ncbi Measles in Minsk, Belarus, 2001-2003: clinical, virological and serological parameters
    A V Atrasheuskaya
    Laboratory of Immunology Safety, Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
    J Clin Virol 34:179-85. 2005
  7. ncbi Acute infectious mononucleosis and coincidental measles virus infection
    A V Atrasheuskaya
    Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
    J Clin Virol 31:160-4. 2004
  8. pmc Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice
    A V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
    Clin Exp Immunol 136:207-14. 2004
  9. ncbi Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004
    A V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
    Clin Microbiol Infect 13:670-6. 2007
  10. doi Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005
    A V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
    Vaccine 26:2111-8. 2008

Collaborators

  • Larisa I Karpenko
  • S A Rubin
  • Sergei I Bazhan
  • Vasily A Evseenko
  • A V Atrasheuskaya
  • A A Neverov
  • Sofia V Perekrest
  • M V Kulak
  • Alena V Atrasheuskaya
  • S N Kameneva
  • T M Fredeking
  • Alena Atrasheuskaya
  • Nataliya S Novikova
  • Elena A Korneva
  • Vernon J Rogers
  • Yurii V Loskutov
  • Taissia V Abramova
  • Elena M Blatun
  • Michail V Kulak
  • Igor A Karpov
  • Alina Atrasheuskaya
  • N L Maksimov
  • E M Blatun
  • I A Karpov
  • E K Bukin
  • Terry M Fredeking
  • Peter Petzelbauer

Detail Information

Publications16

  1. ncbi Changes in immunoreactivity of orexin-A-positive neurons after intravenous lipopolysaccharide injection
    Sofia V Perekrest
    Department of General Pathology and Pathophysiology, State Research Institute of Experimental Medicine RAMS, Saint Petersburg, Russia
    Med Sci Monit 14:BR127-33. 2008
    ..This study sought to investigate the distribution of orexin in hypothalamic orexin-containing neurons during the first 6 hours after an intravenous injection of a lipopolysaccharide...
  2. ncbi Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection
    Alena Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, Russia
    FEMS Immunol Med Microbiol 35:33-42. 2003
    ..05). Our model supports the view that activation of innate immune response is at least partially responsible for mortality in DEN-2 infection, and in line with this concept, anti-TNF treatment significantly reduces mortality rates...
  3. ncbi Experimental study on the possibility of treatment of some hemorrhagic fevers
    G Ignatyev
    State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, 633159, Koltsovo, Russia
    J Biotechnol 83:67-76. 2000
    ..5 ml (2000 U ml(-1); 1 U of the antiserum neutralises 0.03 ng of TNF-alpha), everyday, within 6 days from the third day after the challenge...
  4. ncbi Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003
    Alena V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region, Russia
    Vaccine 25:4651-8. 2007
    ..Our results demonstrate the importance of assaying for neutralizing antibody and support the assertion that antigenic differences between wild type and vaccine MuV strains may play a role in cases of breakthrough infection in vaccinees...
  5. ncbi Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus
    A V Atrasheuskaya
    Laboratory of Immunology Safety, Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
    Vaccine 24:1530-6. 2006
    ..The L-3 mumps vaccine virus can be shed and transmitted horizontally, even to subjects previously vaccinated with the same virus...
  6. ncbi Measles in Minsk, Belarus, 2001-2003: clinical, virological and serological parameters
    A V Atrasheuskaya
    Laboratory of Immunology Safety, Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
    J Clin Virol 34:179-85. 2005
    ..The absence of information on measles virus genotypes circulating in the Republic of Belarus has made it difficult to asses the situation...
  7. ncbi Acute infectious mononucleosis and coincidental measles virus infection
    A V Atrasheuskaya
    Institute of Molecular Biology, State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region 630559, Russia
    J Clin Virol 31:160-4. 2004
    ..Recognizing the infectious etiology of concomitant infections is important for both clinicians and epidemiologists...
  8. pmc Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice
    A V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
    Clin Exp Immunol 136:207-14. 2004
    ..The successful cytokine treatment schemes in this orthopoxvirus model system may have important implications in the treatment of viral diseases in humans and, in particular, of variola virus infection...
  9. ncbi Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004
    A V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
    Clin Microbiol Infect 13:670-6. 2007
    ..Consistent with previous reports, mumps virus genotypes C and H continue to circulate in Novosibirsk...
  10. doi Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005
    A V Atrasheuskaya
    State Research Center of Virology and Biotechnology Vector, Koltsovo, Russia
    Vaccine 26:2111-8. 2008
    ....
  11. ncbi Pathogenesis of infectious disease of mice caused by H5N1 avian influenza virus
    V A Evseenko
    Vector State Research Center of Virology and Biotechnology, Novosibirsk Region, Koltsovo, Russia
    Bull Exp Biol Med 146:766-9. 2008
    ..Clinical, morphological, and immunological characteristics of the experimental infection caused by highly pathogenic A/duck/Tuva/01/06/ (H5N1) virus are described...
  12. pmc Changes in immune parameters and their correction in human cases of tick-borne encephalitis
    A V Atrasheuskaya
    State Research Centre of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Region, Russia
    Clin Exp Immunol 131:148-54. 2003
    ..Children had the highest levels of IL-6, which were not neurotoxic...
  13. ncbi Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen
    Larisa I Karpenko
    The Joint Stock Company Vector Best, The State Research Center of Virology and Biotechnology Vector, Novosibirsk Region, 630559 Koltsovo, Russia
    Vaccine 22:1692-9. 2004
    ..The most significant responses were produced when pcDNA-TCI was delivered by Salmonella...
  14. ncbi Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens
    Sergei I Bazhan
    The State Research Center of Virology and Biotechnology Vector, 630559 Koltsovo, Novosibirsk Region, Russia
    Vaccine 22:1672-82. 2004
    ..It has been demonstrated that DNA vaccine can induce both specific T cell responses (CTL and blast transformation) and specific antibodies in mice immunized with pcDNA-TCI...
  15. ncbi Construction of artificial virus-like particles exposing HIV epitopes, and the study of their immunogenic properties
    Larisa I Karpenko
    The State Research Center of Virology and Biotechnology Vector, The Joint Stock Company Vector Best 630559, Novosibirsk Region, Koltsovo, Russia
    Vaccine 21:386-92. 2003
    ..The dsRNA and the proteins were linked with spermidine-polyglucin-glutathione conjugates. Particles exposing HIV-1 epitopes were constructed, and their immunogenicity tested...
  16. pmc Experimental infection of H5N1 HPAI in BALB/c mice
    Vasily A Evseenko
    State Research Center of Virology and Biotechnology Vector of Rospotrebnadzor, Koltsovo, Russia
    Virol J 4:77. 2007
    ..In 2006 several outbreaks have occurred. To develop new vaccines and antiviral therapies, animal models had to be investigated. We choose highly pathogenic strain for these studies...